EP 1618890 A1 20060125 - Use of antibodies in a very low dose for the vaccination against cancer
Title (en)
Use of antibodies in a very low dose for the vaccination against cancer
Title (de)
Verwendung von Antikörpern in einer sehr geringen Dosis zur Impfung gegen Krebs
Title (fr)
Utilisation d'anticorps en très faibles doses pour vaccination contre le cancer
Publication
Application
Priority
EP 04450149 A 20040720
Abstract (en)
The use of an antibody directed against the cellular membrane antigen EpCAM for the production of a pharmaceutical preparation for the prophylactic and/or therapeutic active immunization against cancer is provided whereby the antibody is in an amount of 1 ng to 9 µg.
IPC 8 full level
A61K 39/395 (2006.01); A61K 39/39 (2006.01); A61P 35/00 (2006.01); C07K 16/30 (2006.01)
CPC (source: EP US)
A61P 35/00 (2018.01 - EP); C07K 16/30 (2013.01 - EP US); A61K 2039/505 (2013.01 - EP US); A61K 2039/545 (2013.01 - EP US); A61K 2039/55505 (2013.01 - EP US)
Citation (search report)
- [X] WO 0041722 A1 20000720 - IGENEON GMBH [AT], et al
- [X] EP 1230932 A2 20020814 - IGENEON KREBS IMMUNTHERAPIE [AT]
- [X] EP 1140168 A1 20011010 - IGENEON KREBS IMMUNTHERAPIE [AT]
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
EP 1618890 A1 20060125; EP 1618890 B1 20101006; AT E483473 T1 20101015; DE 602004029455 D1 20101118; US 2006018901 A1 20060126
DOCDB simple family (application)
EP 04450149 A 20040720; AT 04450149 T 20040720; DE 602004029455 T 20040720; US 18529905 A 20050720